Automated insulin delivery systems are safe, effective, and well-received by older adults with type 1 diabetes, challenging ...

Rhys Evans has been cycle touring with Type 1 diabetes for many years, but limited the distance. Following a tour across ...

New research from Washington State University in collaboration with five other institutions suggests that automated insulin ...

"The risk of diabetic ketoacidosis linked to continuous subcutaneous insulin infusion in type 1 diabetes has significantly ...

Why understanding the differences between Type 1 and Type 2 diabetes is essential for better health management and effective ...

New research suggests that automated insulin delivery (AID) systems are safe and effective for use by older adults with type 1 diabetes. The findings counter common assumptions that older adults would ...

Adults with type 1 diabetes who initiated treatment with a bionic pancreas at a primary care site experienced similar glycemic benefits as those starting the device through an endocrinologist, ...

An early-morning rise in blood sugar is common in people with diabetes. Find out more about why it happens and how to prevent ...

Tandem Diabetes Care, Inc.’s TNDM fourth-quarter 2024 performance was driven by its impressive range of new products. The company’s impressive strategic initiatives provide a favorable opportunity for ...

Tandem Diabetes Care, Inc. reported strong Q4 2024 earnings, but shares declined 30%. Click for my TNDM stock update in light ...

Bernstein downgraded Tandem Diabetes (TNDM) to Market Perform from Outperform with a price target of $25, down from $35. The firm notes Tandem ...